Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trifluoperazine for Treatment of Coronavirus (COVID-19)
IRCT20200329046892N1Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- May 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of trifluoperazine in coronavirus disease 2019 (COVID-19), sponsored by Guilan University of Medical Sciences. Started May 2020; status: completed.
02
Drugs
trifluoperazine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20200329046892N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200329046892N1.